Publication date: Oct 07, 2024
| Concepts | Keywords |
|---|---|
| Bnt162b2 | Amplifying |
| Covid | Arct |
| Month | Covid |
| Mrna | Dis |
| Vaccines | Immune |
| Infect | |
| Lancet | |
| Month | |
| Mrna | |
| Persistence | |
| Self | |
| Vaccine | |
| Vaccines |
Original Article
(Visited 1 times, 1 visits today)
12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine.
